Literature DB >> 3166737

Tryptophan degradation in patients infected by human immunodeficiency virus.

E R Werner1, D Fuchs, A Hausen, H Jaeger, G Reibnegger, G Werner-Felmayer, M P Dierich, H Wachter.   

Abstract

Tryptophan and kynurenine were measured retrospectively in sera of 11 male patients with advanced human immunodeficiency virus (HIV) infection (Walter Reed stages 4 and 6). Tryptophan levels are significantly reduced to less than 50% in patients with HIV infection and kynurenine levels significantly elevated when compared to sex and age matched controls. The decrease of tryptophan levels might contribute to neurologic symptoms often associated with HIV infection. Since interferon-gamma induces degradation of tryptophan via the kynurenine pathway, the present results may be consistent with enhanced endogenous production of interferon-gamma in advanced HIV infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166737     DOI: 10.1515/bchm3.1988.369.1.337

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  23 in total

1.  Decreased plasma ratio of tryptophan to competing large neutral amino acids in human immunodeficiency virus type 1 infected subjects: possible implications for development of neuro-psychiatric disorders.

Authors:  T Eriksson; L Lidberg
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans.

Authors:  Sulggi A Lee; Joel A Mefford; Yong Huang; John S Witte; Jeffrey N Martin; David W Haas; Paul J Mclaren; Taisei Mushiroda; Michiaki Kubo; Helen Byakwaga; Peter W Hunt; Deanna L Kroetz
Journal:  AIDS       Date:  2016-07-17       Impact factor: 4.177

Review 3.  Animal models for depression associated with HIV-1 infection.

Authors:  Isabella Cristina Gomes Barreto; Patricia Viegas; Edward B Ziff; Elisabete Castelon Konkiewitz
Journal:  J Neuroimmune Pharmacol       Date:  2013-12-12       Impact factor: 4.147

4.  Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression.

Authors:  Marcus A Lawson; Keith W Kelley; Robert Dantzer
Journal:  Brain Behav Immun       Date:  2011-05-17       Impact factor: 7.217

5.  Kynurenine pathway metabolites in humans: disease and healthy States.

Authors:  Yiquan Chen; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2009-01-08

6.  HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.

Authors:  Adriano Boasso; Jean-Philippe Herbeuval; Andrew W Hardy; Stephanie A Anderson; Matthew J Dolan; Dietmar Fuchs; Gene M Shearer
Journal:  Blood       Date:  2006-12-07       Impact factor: 22.113

7.  Neopterin concentrations in serum and cerebrospinal fluid in HTLV-I infected individuals.

Authors:  A Ali; P Rudge; A G Dalgleish
Journal:  J Neurol       Date:  1992-05       Impact factor: 4.849

8.  Activation of the Serotonin Pathway is Associated with Poor Outcome in COPD Exacerbation: Results of a Long-Term Cohort Study.

Authors:  Marc A Meier; Manuel Ottiger; Alaadin Vögeli; Christian Steuer; Luca Bernasconi; Robert Thomann; Mirjam Christ-Crain; Christoph Henzen; Claus Hoess; Werner Zimmerli; Andreas Huber; Beat Mueller; Philipp Schuetz
Journal:  Lung       Date:  2017-04-22       Impact factor: 2.584

Review 9.  Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease.

Authors:  J Nogales-Gaete; K Syndulko; W W Tourtellotte
Journal:  Ital J Neurol Sci       Date:  1992-11

10.  Nocturnal sleep EEG in patients with HIV infection.

Authors:  M Wiegand; A A Möller; W Schreiber; J C Krieg; D Fuchs; H Wachter; F Holsboer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.